1. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
- Author
-
Manuel Durán-Ferrer, Rubén Villalba, Paloma Fernández-Pacheco, Cristina Tena-Tomás, Miguel-Ángel Jiménez-Clavero, José-Antonio Bouzada, María-José Ruano, Jovita Fernández-Pinero, Marisa Arias, Javier Castillo-Olivares, Montserrat Agüero, Jiménez-Clavero, Miguel-Ángel, Fernández-Pinero, Jovita, Arias, Marisa, Castillo-Olivares, Javier, Jiménez-Clavero, Miguel-Ángel [0000-0003-2125-9743], Fernández-Pinero, Jovita [0000-0001-9919-0112], Arias, Marisa [0000-0001-6044-2968], Castillo-Olivares, Javier [0000-0003-3453-8557], and Apollo - University of Cambridge Repository
- Subjects
live attenuated vaccine ,virus isolation ,Viral Vaccines ,Antibodies, Viral ,Serogroup ,sero-neutralization test ,test precocity ,African horse sickness ,ELISA ,PCR ,Experimental infection ,Live attenuated vaccine ,Sero-neutralization test ,Test precocity ,Tests performance characteristics ,Virus isolation ,Infectious Diseases ,experimental infection ,Virology ,African Horse Sickness ,African Horse Sickness Virus ,Animals ,Horses ,tests performance characteristics - Abstract
This study described the clinical, virological, and serological responses of immunologically naïve and vaccinated horses to African horse sickness virus (AHSV) serotype 9. Naïve horses developed a clinical picture resembling the cardiac form of African horse sickness. This was characterized by inappetence, reduced activity, and hyperthermia leading to lethargy and immobility-recumbency by days 9-10 post-infection, an end-point criteria for euthanasia. After challenge, unvaccinated horses were viremic from days 3 or 4 post-infection till euthanasia, as detected by serogroup-specific (GS) real time RT-PCR (rRT-PCR) and virus isolation. Virus isolation, antigen ELISA, and GS-rRT-PCR also demonstrated high sensitivity in the post-mortem detection of the pathogen. After infection, serogroup-specific VP7 antibodies were undetectable by blocking ELISA (b-ELISA) in 2 out of 3 unvaccinated horses during the course of the disease (9-10 dpi). Vaccinated horses did not show significant side effects post-vaccination and were largely asymptomatic after the AHSV-9 challenge. VP7-specific antibodies could not be detected by the b-ELISA until day 21 and day 30 post-inoculation, respectively. Virus neutralizing antibody titres were low or even undetectable for specific serotypes in the vaccinated horses. Virus isolation and GS-rRT-PCR detected the presence of AHSV vaccine strains genomes and infectious vaccine virus after vaccination and challenge. This study established an experimental infection model of AHSV-9 in horses and characterized the main clinical, virological, and immunological parameters in both immunologically naïve and vaccinated horses using standardized bio-assays.
- Published
- 2022